• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.

2017 Valneva Annual Business Report

Download 2017 Valneva Annual Business Report

July 2, 2018  

Valneva Announces Significant Progress of its Lyme Disease Vaccine Candidate

Read more    

— Stock information


— June 29, 2018
Valneva Announces Successful Outcome of its AGM and Renewal of the Term of Office of its Management Board Members

Read more
AGM Results
— Financial Calendar

August 2, 2018
HY 2018 Financial Statements

See all dates


learn more
play video Company Video

– Upcoming conferences

September 7
Goldman Sachs Biotech Symposium, London

October 8-9
European Large & Midcap Event, Paris

October 29-31

World Vaccine Congress Europe, Lisbon

November 13-14
Stifel 2018 Healthcare Conference, New York

Please update your browser...